- A. In this chapter, the following terms have the meanings indicated.
B. Terms Defined.
(1) Applicant.
- (a) “Applicant” means a person located in Maryland who applies for the financial assistance provided pursuant to this chapter.
- (b) “Applicant” includes a public or private institution of higher education and a public or private corporation.
- (2) “Commission” means the Stem Cell Research Commission created under §10-431 of the Act.
- (3) “Corporation” means the Maryland Technology Development Corporation.
- (4) “Financial assistance” means a grant or loan from the Fund.
- (5) “Fund” means the Maryland Stem Cell Research Fund created under §10-434 of the Act.
- (6) “Grantee” means an applicant who has been awarded financial assistance, whether in the form of a grant or a loan.
- (7) “Human stem cell” means a stem cell derived from human tissue.
- (8) “Institutional Review Board (IRB)” has the meaning stated in 45 CFR §46.102.
- (9) “Program” means the program for State-funded stem cell research authorized by the Act.
(10) “Stem cell research” means basic, translational, or clinical research that:
- (a) Is conducted in Maryland; and
(b) Uses human stem cells derived from:
- (i) Tissue obtained after the birth of a human being; or
- (ii) Unused IVF material.
- (11) “State-funded stem cell research” means, in addition to the meaning stated in §10-429(i) of the Act, stem cell research that receives financial assistance.
- (12) “Stem cell” has the meaning stated in §10-429(j) of the Act.
- (13) “Unused IVF material” means the unused material described in §§10-438 and 10-439 of the Act.
Authority: Economic Development Article, §10-409 and 10-441, Annotated Code of Maryland
Effective date: August 27, 2007 (34:17 Md. R. 1510)
Regulations .01—.11 under COMAR 14.04.01, Stem Cell Research Commission recodified to be COMAR 14.04.08, Stem Cell Research Commission effective December 30, 2019 (46:26 Md. R. 1167)
Regulation .03B amended effective February 22, 2021 (48:4 Md. R. 178)
Regulation .05A amended effective February 22, 2021 (48:4 Md. R. 178)